Literature DB >> 4080332

Clinical applications of the organic dye laser.

F A L'Esperance.   

Abstract

Clinical research utilizing the yellow, orange and red wavelengths of the dye laser (Rhodamine 6G and MD-631) indicates that the liquid organic dye laser may have considerable applications in ocular photodynamic and photocoagulation therapy. The effectiveness of the dye laser as a photodynamic (photoradiation) and photocoagulation source is due to the large numbers of wavelengths of relatively high output power that can be produced in the visible spectrum. Therefore, a target tissue can be selectively destroyed with minimal laser energy necessarily transmitted through the refractive media. The dye laser, as a photoradiation or photocoagulation system, should prove valuable in the therapy of ocular disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4080332     DOI: 10.1016/s0161-6420(85)33819-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Dye laser photocoagulation of macular subretinal neovascularization in pathological myopia. A randomized study of three different wavelengths.

Authors:  R Brancato; U Menchini; A Pece; C Capoferri; P Avanza; E Radrizzani
Journal:  Int Ophthalmol       Date:  1988-02       Impact factor: 2.031

2.  Animal experiments for the determination of an optimal wavelength for retinal coagulations.

Authors:  M Vogel; F P Schäfer; M Stuke; K Müller; S Theuring; A Morawietz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

Review 3.  Recent Advances in Age-Related Macular Degeneration Therapies.

Authors:  Marie Fabre; Lou Mateo; Diana Lamaa; Stéphanie Baillif; Gilles Pagès; Luc Demange; Cyril Ronco; Rachid Benhida
Journal:  Molecules       Date:  2022-08-10       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.